Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma.

Krumbholz M, Woessmann W, Zierk J, Seniuk D, Ceppi P, Zimmermann M, Singh VK, Metzler M, Damm-Welk C.

Oncotarget. 2018 May 29;9(41):26543-26555. doi: 10.18632/oncotarget.25489. eCollection 2018 May 29.

2.

Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.

García-Ramírez I, Bhatia S, Rodríguez-Hernández G, González-Herrero I, Walter C, González de Tena-Dávila S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A, Domínguez V, Pintado B, Blanco O, Alonso-López D, De Las Rivas J, Martín-Lorenzo A, Jiménez R, García Criado FJ, García Cenador MB, Lossos IS, Vicente-Dueñas C, Borkhardt A, Hauer J, Sánchez-García I.

EMBO J. 2018 Jul 13;37(14). pii: e98783. doi: 10.15252/embj.201798783. Epub 2018 Jun 7.

3.

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

Stadler S, Singh VK, Knörr F, Damm-Welk C, Woessmann W.

Cancers (Basel). 2018 Apr 10;10(4). pii: E114. doi: 10.3390/cancers10040114. Review.

4.

Duodenocolonic Fistula As A Rare Complication of Intestinal Burkitt Lymphoma in a Three-Year-Old Boy.

Okuda KV, Laass M, Schuchardt K, Lange BS, Knöfler R, Fitze G, Woessmann W, Suttorp M.

Klin Padiatr. 2018 Apr;230(3):138-141. doi: 10.1055/a-0586-4045. Epub 2018 Apr 4.

PMID:
29618138
5.

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma.

Schleussner N, Merkel O, Costanza M, Liang HC, Hummel F, Romagnani C, Durek P, Anagnostopoulos I, Hummel M, Jöhrens K, Niedobitek A, Griffin PR, Piva R, Sczakiel HL, Woessmann W, Damm-Welk C, Hinze C, Stoiber D, Gillissen B, Turner SD, Kaergel E, von Hoff L, Grau M, Lenz G, Dörken B, Scheidereit C, Kenner L, Janz M, Mathas S.

Leukemia. 2018 Mar 28. doi: 10.1038/s41375-018-0045-9. [Epub ahead of print]

PMID:
29588546
6.

CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series.

Ruf S, Hebart H, Hjalgrim LL, Kabickova E, Lang P, Steinbach D, Schwabe GC, Woessmann W.

Pediatr Blood Cancer. 2018 Jun;65(6):e27003. doi: 10.1002/pbc.27003. Epub 2018 Mar 7.

PMID:
29512859
7.

Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Knörr F, Damm-Welk C, Ruf S, Singh VK, Zimmermann M, Reiter A, Woessmann W.

Haematologica. 2018 Mar;103(3):477-485. doi: 10.3324/haematol.2017.177972. Epub 2017 Dec 14.

8.

Corrigendum: Clinical and Molecular Heterogeneity of RTEL1 Deficiency.

Speckmann C, Sahoo SS, Rizzi M, Hirabayashi S, Karow A, Serwas NK, Hoemberg M, Damatova N, Schindler D, Vannier JB, Boulton SJ, Pannicke U, Göhring G, Thomay K, Verdu-Amoros JJ, Hauch H, Woessmann W, Escherich G, Laack E, Rindle L, Seidl M, Rensing-Ehl A, Lausch E, Jandrasits C, Strahm B, Schwarz K, Ehl SR, Niemeyer C, Boztug K, Wlodarski MW.

Front Immunol. 2017 Oct 2;8:1250. doi: 10.3389/fimmu.2017.01250. eCollection 2017.

9.

Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.

Landmann E, Burkhardt B, Zimmermann M, Meyer U, Woessmann W, Klapper W, Wrobel G, Rosolen A, Pillon M, Escherich G, Attarbaschi A, Beishuizen A, Mellgren K, Wynn R, Ratei R, Plesa A, Schrappe M, Reiter A, Bergeron C, Patte C, Bertrand Y.

Haematologica. 2017 Dec;102(12):2086-2096. doi: 10.3324/haematol.2015.139162. Epub 2017 Oct 5.

10.

Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis.

Ammann S, Lehmberg K, Zur Stadt U, Klemann C, Bode SFN, Speckmann C, Janka G, Wustrau K, Rakhmanov M, Fuchs I, Hennies HC, Ehl S; HLH study of the GPOH.

J Clin Immunol. 2017 Nov;37(8):770-780. doi: 10.1007/s10875-017-0443-1. Epub 2017 Sep 21.

PMID:
28936583
11.

Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma.

Mussolin L, Pillon M, Zimmermann M, Carraro E, Basso G, Knoerr F, Woessmann W, Damm-Welk C.

Br J Haematol. 2017 Aug 31. doi: 10.1111/bjh.14864. [Epub ahead of print] No abstract available.

PMID:
28857122
12.

Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma.

Makarova O, Oschlies I, Müller S, Ruf S, Zimmermann M, Niggli F, Attarbaschi A, Kabickova E, Klapper W, Woessmann W, Burkhardt B.

Br J Haematol. 2017 Aug 2. doi: 10.1111/bjh.14868. [Epub ahead of print] No abstract available.

PMID:
28771659
13.

Clinical and Molecular Heterogeneity of RTEL1 Deficiency.

Speckmann C, Sahoo SS, Rizzi M, Hirabayashi S, Karow A, Serwas NK, Hoemberg M, Damatova N, Schindler D, Vannier JB, Boulton SJ, Pannicke U, Göhring G, Thomay K, Verdu-Amoros JJ, Hauch H, Woessmann W, Escherich G, Laack E, Rindle L, Seidl M, Rensing-Ehl A, Lausch E, Jandrasits C, Strahm B, Schwarz K, Ehl SR, Niemeyer C, Boztug K, Wlodarski MW.

Front Immunol. 2017 May 1;8:449. doi: 10.3389/fimmu.2017.00449. eCollection 2017. Erratum in: Front Immunol. 2017 Oct 02;8:1250.

14.

Long-term follow-up of meningeal spread of otherwise stage 4S neuroblastoma without treatment.

Meinhardt A, Becker B, Hero B, Gramsch C, Steiner D, Woessmann W.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26445. Epub 2017 Jan 18. No abstract available.

PMID:
28097782
15.

Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report.

Hebart H, Lang P, Woessmann W.

Ann Intern Med. 2016 Oct 18;165(8):607-608. doi: 10.7326/L16-0037. No abstract available.

PMID:
27750310
16.

Pigmented squamous cell carcinoma in an adolescent following long-term treatment with voriconazole.

Verdú-Amorós J, Wilbrand JF, Mayser P, Gattenloehner S, Woessmann W.

Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26280. Epub 2016 Oct 3. No abstract available.

PMID:
27696679
17.

Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.

Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group.

Haematologica. 2016 Dec;101(12):1581-1591. Epub 2016 Aug 11.

18.

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK.

Damm-Welk C, Siddiqi F, Fischer M, Hero B, Narayanan V, Camidge DR, Harris M, Burke A, Lehrnbecher T, Pulford K, Oschlies I, Siebert R, Turner S, Woessmann W.

J Cancer. 2016 Jun 30;7(11):1383-7. doi: 10.7150/jca.15238. eCollection 2016.

19.

Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.

K Singh V, Werner S, Hackstein H, Lennerz V, Reiter A, Wölfel T, Damm-Welk C, Woessmann W.

Clin Exp Immunol. 2016 Oct;186(1):96-105. doi: 10.1111/cei.12842. Epub 2016 Aug 16.

20.

Pancytopenia During Parenteral Nutrition.

Moser O, Becker B, Hauch H, Woessmann W.

Klin Padiatr. 2016 Nov;228(6-07):332-333. Epub 2016 May 11. No abstract available.

PMID:
27167899

Supplemental Content

Loading ...
Support Center